The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2018. The top activity for fund was in 2017.
Among the most popular fund investment industries, there are Biotechnology, Medical. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight UNITY Biotechnology.
The typical case for the fund is to invest in rounds with more than 10 participants. Despite the Pivotal Alpha Limited, startups are often financed by Venrock, ARCH Venture Partners, WuXi AppTec. The meaningful sponsors for the fund in investment in the same round are Venrock, Partner Fund Management, Invus. In the next rounds fund is usually obtained by Venrock, The Longevity Fund, Partner Fund Management.
Related Funds
| Fund Name | Location |
| AP Capital Partners | Florida, Orlando, United States |
| Aristagora VC | Israel, Tel Aviv, Tel Aviv District |
| BDC ICE Fund (Cleantech) | Canada, Montréal, Quebec |
| Commonwealth Seed Capital | Frankfort, Kentucky, United States |
| Fox Corporation | New York, New York, United States |
| Highview financial group | Canada, Oakville, Ontario |
| Jiayuan Capital Management | China, Guangdong, Shenzhen |
| Lanyan Capital | - |
| MetLife Foundation | Distrito Federal, Mexico, Mexico City |
| Mountain Alliance | Bayern, Germany, Munich |
| Orios Venture Partners | India, Maharashtra, Mumbai |
| Qiushi Venture Capital | China, Guizhou, Liaoning |
| Real Dania | - |
| Shanghai Zhonglai | China, Shanghai |
| Shavit Capital | Israel, Jerusalem, Jerusalem District |
| Shengming Enterprise management | China, Chongqing, Yubei |
| Standard Chartered Private Equity | Central Region, Singapore, Singapore |
| Sumitomo Corporation | Chiyoda, Japan |
| Zeeuws Investerings Fonds | Netherlands, Vlissingen, Zeeland |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
UNITY Biotechnology | $55M | 19 Mar 2018 | California, United States | ||
UNITY Biotechnology | $35M | 17 Aug 2017 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
UNITY Biotechnology | $55M | 19 Mar 2018 | California, United States | ||
UNITY Biotechnology | $35M | 17 Aug 2017 | California, United States |
